Trials / Completed
CompletedNCT00840580
Effect on Wound Healing of Vigamox Versus Cravit
Prospective, Randomized Study Comparing Effect on Wound Healing of Vigamox (Moxifloxacin 0.5% Ophthalmic Solution) and Cravit (Levofloxacin 0.5% Ophthalmic Solution) Administered Post-Surgically in Patients Undergoing Cataract Extraction
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 79 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study was to compare the effects of Vigamox and Cravit on corneal wound healing after cataract surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Moxifloxacin 0.5% ophthalmic solution (Vigamox) | One drop 4 times a day in study eye for one week prior to surgery, followed by one drop 4 times a day for two weeks beginning Day 1 post surgery. |
| DRUG | Levofloxacin 0.5% ophthalmic solution (Cravit) | One drop 4 times a day in study eye for one week prior to surgery, followed by one drop 4 times a day for two weeks beginning Day 1 post surgery. |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2009-09-01
- First posted
- 2009-02-10
- Last updated
- 2012-07-23
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00840580. Inclusion in this directory is not an endorsement.